Breast cancer drug shows potential in patients with skin metastases

[News]

A study presented at the ESMO Congress reveals how the drug tucatinib led to a reduction in skin metastases for patients with breast cancer.

More... (http://www.medicalnewstoday.com/articles/313476.php)